Apeiron Investment Group

Apeiron Investment Group, based in Sliema, Malta, is a private family office and multi-asset investment company founded by renowned entrepreneur Christian Angermayer. The group operates with a long-term investment horizon, focusing on disruptive technologies and industries with significant growth potential. Apeiron's investment philosophy emphasizes creating enduring value across its diverse portfolio, which spans both early-stage ventures and publicly listed companies, reflecting a flexible and opportunistic approach to capital deployment.

Apeiron's core investment sectors include Life Sciences, with a particular emphasis on biotech and mental health innovation; FinTech & Crypto, exploring the future of financial services and digital assets; FutureTech, encompassing areas like artificial intelligence, blockchain, and advanced computing; and Experiences, Hospitality & Happiness, investing in consumer-centric businesses that enhance quality of life. The group is known for its hands-on approach, often taking significant stakes and providing strategic guidance to its portfolio companies. Their involvement often extends beyond capital, leveraging Angermayer's extensive network and entrepreneurial expertise.

Apeiron has built an impressive portfolio of high-growth companies. Among its most notable successes are Atai Life Sciences (NASDAQ: ATAI) and Compass Pathways (NASDAQ: CMPS), both pioneers in psychedelic-assisted therapies that have gone public, demonstrating Apeiron's foresight in emerging and often controversial sectors. As of early 2024, Apeiron Investment Group has made over 100 investments, with Crunchbase reporting 104 investments and 10 lead investments, indicating their active role in shaping the growth trajectories of their portfolio companies.

Given its nature as a family office with a broad mandate, Apeiron's typical initial investment sizes are flexible. For early-stage ventures (Seed to Series B), their first checks often range from approximately $1 million to $10 million, particularly when taking a lead or significant co-lead position. However, their capacity allows for much larger follow-on investments or direct investments into more mature private or public entities, reflecting their commitment to long-term value creation across their diverse portfolio.